Cell & Gene Therapy Core
Vector Core | CRISPR Facility | iPS Core
Custom-Made Tools for Your Research
In January 2022, Lund Stem Cell Center (StemTherapy) and MultiPark merged the former iPSC, CRISPR and vector platforms into the new Cell and Gene Therapy Core Facility, located at BMC B10.
Today, the Cell and Gene Therapy Core Facility, situated within the Biomedical Center at the Faculty of Medicine at Lund University, serves as an open-access infrastructure offering a range of services including AAV and LV vector production, mRNA production, iPSC-reprogramming, iPSC-edits, and CRISPR experimental designs.
The core facility welcomes members of Lund Stem Cell Center (StemTherapy) & MultiPark, as well as academic users from both national and international institutions.
News from the Core
Updates:
New prices from January 1, 2025.
New order system for lentivirus, AAV and maxi-preps from Feb 1st 2025.
Events:
CRISPR Symposium - on 28th January, 2025.
New Courses:
Gene-editing technologies .NEW
Course in iPSCs - handling, maintenance and understanding of human pluripotent stem cells - Next course in autumn 2025.
New Services:
Custom mRNA production. Ask us how!
Quality Controlled iPS Stocks
Contact Us:
cellandgenetherapy [at] med [dot] lu [dot] se (cellandgenetherapy[at]med[dot]lu[dot]se)
Visit Us:
Cell and Gene Therapy Core Facility
Lund University,
BMC B10, Solvegatan 19,
221 84 Lund, Sweden
